Recently, Hrain Biotechnology Co., Ltd. was recognized as the 2020 National High-tech Enterprise in Shanghai (Certificate No. GR202031007051) after being approved by the Office of the Leading Group for the Recognition and Management of National High-tech Enterprises.
The recognition of high-tech enterprises must have the core technology with independent intellectual property rights, to ongoing research and development of scientific and technological achievements and technical achievements transformation, the proportion of scientific and technological talents, research and development costs, enterprise innovation strength, growth index, etc., and meet in the high-tech fields of the national key support within the knowledge intensive and technology-intensive economic entity of this qualification. The recognition of Hrain is the recognition of the company's technical strength, innovation ability and development potential. At the same time, it stimulates the enthusiasm of the company's independent innovation, improves the ability of scientific and technological innovation, and strengthens the confidence for the next step of development. Hrain will continue to contribute its strength to China's health and promote the development of technological innovation in cell therapy.